Aeye Health announced a strategic partnership with Ford Medical that will bring Aeye's fully autonomous diabetic eye exam screening solutions to pharmacies and non-acute centers nationwide.

AEYE-DS, Aeye Health's AI-driven technology, enables point-of-care screening for patients who may not regularly see an eye specialist. AEYE-DS is the first and only FDA-cleared AI solution compatible with a portable camera, making retinal screening feasible in a pharmacy setting, the company said in a press release. The solution requires just 1 image per eye, and delivers accurate AI results in just 1 minute, according to Aeye Health. 

Through this partnership, Ford Medical will distribute Aeye Health's FDA-cleared AI screening solutions, enabling pharmacies and non-acute centers to offer an in-house, non-invasive eye exam that delivers immediate diagnostic results without the need for a specialist. The solution is fully reimbursable under an existing CPT code, the company said.